Changes in seizure severity and quality of life in patients with refractory partial epilepsy

Epilepsy and Behavior

Volumn 19, Issue 3, 2010, Pages 409-413

  Sancho, Jerónimo ^a   Iváñez, Vicente ^b   Molins, Albert ^c   López Gómez, Vanessa ^d   Masramón, Xavier ^e   Pérez, María ^d  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d PFIZER INC   (United States)

^e European Biometrics Institute   (Spain)

Author keywords

Antiepileptic; Epilepsy; Quality of life; Refractory; Seizure severity; Sleep Depression Anxiety

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; PHENYTOIN; PREGABALIN; VALPROIC ACID;

ADULT; ANXIETY; ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SEIZURE;

ADULT; ANTICONVULSANTS; ANXIETY; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATION; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TIME FACTORS;

EID: 78649908260     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.08.011     Document Type: Article

References (23)

1. Cramer J.A., French J. Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components. Epilepsia 2001, 42:119-129.
2. Scott-Lennox J., Bryant-Comstock L., Lennox R., Baker G.A. Reliability, validity and responsiveness of a revised scoring system for the Liverpool Seizure Severity Scale. Epilepsy Res 2001, 44:53-63.
3. Baker G.A., Smith D.F., Jacoby A., Hayes J.A., Chadwick D.W. Liverpool Seizure Severity Scale revisited. Seizure 1998, 7:201-205.
4. Vickrey B.G., Berg A.T., Sperling M.R., et al. Relationships between seizure severity and health-related quality of life in refractory localization-related epilepsy. Epilepsia 2000, 41:760-764.
5. Perrine K., Hermann B.P., Meador K.J., et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995, 52:997-1003.
6. Beyenburg S., Mitchell A.J., Schmidt D., Elger C.E., Reuber M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav 2005, 7:161-171.
7. Jones J.E., Hermann B.P., Barry J.J., Gilliam F., Kanner A.M., Meador K.J. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci 2005, 17:172-179.
8. Johnson E.K., Jones J.E., Seidenberg M., Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004, 45:544-550.
9. De Weerd A., de Haas S., Otte A., et al. Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life. Epilepsia 2004, 45:1397-1404.
10. Cramer J.A., Baker G.A., Jacoby A. Development of a new seizure severity questionnaire: initial reliability and validity testing. Epilepsy Res 2002, 48:187-197.
11. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50-55.
12. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
13. Hayes R.D., Stewart A.L. Sleep measures. Measuring functioning and well-being 1992, 3-439. Duke Univ. Press, Durham, NC. A.L. Stewart, J.E. Ware (Eds.).
14. Cramer J.A., Perrine K., Devinsky O., Bryant-Comstock L., Meador K., Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 1998, 39:81-88.
15. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
16. Harden C.L., Maroof D.A., Nikolov B., et al. The effect of seizure severity on quality of life in epilepsy. Epilepsy Behav 2007, 11:208-211.
17. Cramer J.A., Blum D., Reed M., Fanning K. The influence of comorbid depression on seizure severity. Epilepsia 2003, 44:1578-1584. for the Epilepsy Impact Project Group.
18. Hermann B.P., Seidenberg M., Bell B., Woodard A., Rutecki P., Sheth R. Comorbid psychiatric symptoms in temporal lobe epilepsy: association with chronicity of epilepsy and impact on quality of life. Epilepsy Behav 2000, 1:184-190.
19. Bazil C.W. Epilepsy and sleep disturbance. Epilepsy Behav 2003, 4(Suppl. 2):S39-S45.
20. Park S.P., Kwon S.H. Cognitive effects of antiepileptic drugs. J Clin Neurol 2008, 4:99-106.
21. Romigi A., Izzi F., Marciani M.G., et al. Pregabalin as add-on therapy induces REM sleep enhancement in partial epilepsy: a polysomnographic study. Eur J Neurol 2009, 16:70-75.
22. Arain A.M. Pregabalin in the management of partial epilepsy. Neuropsychiatr Dis Treat 2009, 5:407-413.
23. Cramer J.A., Arrigo C., Van Hammee G., Gauer L.J., Cereghino J.J. for the N132 Study Group. Effect of levetiracetam on epilepsy-related quality of life. Epilepsia 2000, 41:868-874.